Fmr LLC Recursion Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,584,858 shares of RXRX stock, worth $32.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,584,858

Previous 6,846,842 18.43%

Holding current value

$32.9 Million

Previous $36.2 Million 21.98%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$3.97 - $5.84 $5.01 Million - $7.37 Million	-1,261,984 Reduced 18.43%	5,584,858 $28.3 Million
Q1 2025 May 12, 2025	SELL	$5.29 - $10.87 $1.19 Million - $2.45 Million	-225,339 Reduced 3.19%	6,846,842 $36.2 Million
Q4 2024 Feb 13, 2025	SELL	$5.7 - $8.27 $7.36 Million - $10.7 Million	-1,291,349 Reduced 15.44%	7,072,181 $47.8 Million
Q3 2024 Nov 13, 2024	BUY	$5.92 - $8.6 $1.01 Million - $1.47 Million	170,810 Added 2.08%	8,363,530 $55.1 Million
Q2 2024 Aug 13, 2024	SELL	$7.35 - $10.05 $7.85 Million - $10.7 Million	-1,068,151 Reduced 11.53%	8,192,720 $61.4 Million
Q1 2024 May 13, 2024	SELL	$9.13 - $15.52 $14.9 Million - $25.4 Million	-1,636,416 Reduced 15.02%	9,260,871 $92.3 Million
Q4 2023 Feb 13, 2024	BUY	$5.09 - $10.79 $1.06 Million - $2.24 Million	207,755 Added 1.94%	10,897,287 $107 Million
Q3 2023 Nov 13, 2023	BUY	$6.59 - $15.86 $40.4 Million - $97.2 Million	6,129,935 Added 134.44%	10,689,532 $81.8 Million
Q2 2023 Aug 11, 2023	SELL	$4.56 - $9.94 $893,139 - $1.95 Million	-195,864 Reduced 4.12%	4,559,597 $34.1 Million
Q1 2023 May 11, 2023	BUY	$6.42 - $9.64 $1.86 Million - $2.79 Million	289,746 Added 6.49%	4,755,461 $31.7 Million
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $1.54 Million - $2.72 Million	214,551 Added 5.05%	4,465,715 $34.4 Million
Q3 2022 Nov 10, 2022	BUY	$7.83 - $13.6 $11.1 Million - $19.2 Million	1,415,312 Added 49.91%	4,251,164 $45.2 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.26 $3.48 Million - $6.39 Million	690,213 Added 32.17%	2,835,852 $23.1 Million
Q1 2022 May 13, 2022	BUY	$6.16 - $18.03 $3.79 Million - $11.1 Million	615,413 Added 40.22%	2,145,639 $15.4 Million
Q4 2021 Feb 14, 2022	SELL	$16.14 - $21.86 $6.94 Million - $9.39 Million	-429,737 Reduced 21.93%	1,530,226 $26.2 Million
Q3 2021 Nov 15, 2021	SELL	$19.03 - $41.33 $4.79 Million - $10.4 Million	-251,638 Reduced 11.38%	1,959,963 $45.1 Million
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $39.8 Million - $82.8 Million	2,211,601 New	2,211,601 $80.7 Million

Others Institutions Holding RXRX

# of Institutions

367

Shares Held

288M

Call Options Held

7.76M

Put Options Held

6.19M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.06B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account